398 related articles for article (PubMed ID: 16493335)
1. [Natural history of hepatitis B infection].
Pol S
Presse Med; 2006 Feb; 35(2 Pt 2):308-16. PubMed ID: 16493335
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology and natural history of hepatitis B].
Pol S
Rev Prat; 2005 Mar; 55(6):599-606. PubMed ID: 15913111
[TBL] [Abstract][Full Text] [Related]
3. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
6. Natural history of hepatitis B.
Marcellin P; Castelnau C; Martinot-Peignoux M; Boyer N
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):63-75. PubMed ID: 15756147
[TBL] [Abstract][Full Text] [Related]
7. [IMMUNOPATHOGENESIS OF OCCULT INFECTION CAUSED BY HEPATITIS B VIRUS].
Semenenko TA; Suslov AP
Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):105-13. PubMed ID: 26950999
[TBL] [Abstract][Full Text] [Related]
8. [Natural history and clinical manifestations of chronic hepatitis B virus].
Carneiro de Moura M; Marinho R
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():11-8. PubMed ID: 19100227
[TBL] [Abstract][Full Text] [Related]
9. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
10. [Natural history of chronic hepatitis B virus infection].
Vildózola Gonzales H; Salinas JL
Rev Gastroenterol Peru; 2009; 29(2):147-57. PubMed ID: 19609330
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
13. Natural history of hepatitis B virus infection: an update for clinicians.
Pungpapong S; Kim WR; Poterucha JJ
Mayo Clin Proc; 2007 Aug; 82(8):967-75. PubMed ID: 17673066
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
15. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease.
Chemin I; Jeantet D; Kay A; Trépo C
Antiviral Res; 2001 Nov; 52(2):117-23. PubMed ID: 11672821
[TBL] [Abstract][Full Text] [Related]
16. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
Ieluzzi D; Covolo L; Donato F; Fattovich G
Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
[TBL] [Abstract][Full Text] [Related]
17. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
[TBL] [Abstract][Full Text] [Related]
19. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
20. Perspectives and control of hepatitis B virus infection in Taiwan.
Lin CL; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
